This article is
- freely available
Anti-Viral Drugs for Human Adenoviruses
School of Biomedical Sciences, Croucher Laboratory for Human Genomics, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong
* Author to whom correspondence should be addressed.
Received: 2 September 2010; in revised form: 23 October 2010 / Accepted: 25 October 2010 / Published: 25 October 2010
(This article belongs to the Special Issue Antivirals
Abstract: There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A–F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed.
Keywords: adenovirus; pharmaceuticals; microRNA
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Waye, M.M.Y.; Sing, C.W. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals 2010, 3, 3343-3354.
Waye MMY, Sing CW. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals. 2010; 3(10):3343-3354.
Waye, Mary Miu Yee; Sing, Chor Wing. 2010. "Anti-Viral Drugs for Human Adenoviruses." Pharmaceuticals 3, no. 10: 3343-3354.